iHuman reports second-quarter loss as revenue declines
iHuman (NYSE:IH) reported second-quarter 2026 financial results, with revenue and user numbers declining while the company moved to a net loss compared with the prior-year period.
iHuman (NYSE:IH) reported second-quarter 2026 financial results, with revenue and user numbers declining while the company moved to a net loss compared with the prior-year period.
CarMax (NYSE:KMX) reported results for the second quarter ended August 31, 2026, with higher vehicle sales, revenue growth, and improved earnings.
Kura Oncology (NASDAQ:KURA) and Caspian Therapeutics presented preclinical findings for KO-7246, an investigational diabetes treatment candidate, at the European Association for the Study of Diabetes (EASD) meeting in Milan.
FreeCast (NASDAQ:CAST) filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, highlighting progress in its transition from technology development toward commercial deployment of its Platform-as-a-Service (PaaS) strategy.
Tesla’s (NASDAQ:TSLA) Full Self-Driving (FSD) system is facing regulatory scrutiny in Europe after the European Transport Safety Council (ETSC) urged European Union member states to reject approval of the driver-assistance technology.
Jaguar Health (NASDAQ:JAGX) announced that an abstract covering preliminary results from an adult short bowel syndrome study has been accepted for presentation at the American College of Gastroenterology (ACG) 2026 meeting.
Pearson (NYSE:PSO) agreed to acquire Workera, a company that provides AI-powered workforce skills assessment solutions for enterprises.
HUTCHMED (NASDAQ:HCM) announced that AstraZeneca (NASDAQ:AZN) submitted a U.S. regulatory application for ORPATHYS in combination with TAGRISSO for patients with MET-driven EGFR-mutated non-small cell lung cancer.
Quantum-Si (NASDAQ:QSI) reported interim results showing that its developmental Proteus protein-sequencing platform outperformed its Platinum Pro system across multiple performance measures.
Hormel Foods (NYSE:HRL) declared a quarterly common-stock dividend of $0.2925 per share, continuing the company’s long history of returning capital to shareholders.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade